PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
19-Jan-2022 JYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS PATIENTS IN GREAT BRITAIN Galapagos NV
18-Jan-2022 Eisbach Bio and MD Anderson announce strategic collaboration to develop medicines targeting epigenetic machinery in oncology Eisbach Bio
18-Jan-2022 Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022 Avance Clinical
17-Jan-2022 Seekyo reinforces scientific advisory board with two new members Andrew Lloyd Associates
13-Jan-2022 Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance Porda
12-Jan-2022 Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO Arcensus GmbH
12-Jan-2022 Shanghai ZhenGe Biotech Raises USD 100 million Round C Led by Goldman Sachs Asset Management and Sofina Shanghai ZhenGe Biotech
12-Jan-2022 Watson-Marlow enhances strong European connections providing further international support for Flexicon Liquid Filling Watson-Marlow Fluid Technology Group
12-Jan-2022 Actimed Therapeutics to Participate at Biotech Showcase 2022 Actimed Therapeutics
11-Jan-2022 AlivaMab Discovery Services Appoints Jane Seagal, PhD, as Vice President of Antibody Discovery AlivaMab Discovery Services
11-Jan-2022 Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One Andrew Lloyd Associates
09-Jan-2022 Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022 SMi Group
07-Jan-2022 HMNC Brain Health to Participate in H.C. Wainwright Bioconnect Conference in January 2022 HMNC Brain Health
06-Jan-2022 Why will Demand for Customized Peptide Synthesis Soar in Asia-Pacific in Future? P&S Intelligence
06-Jan-2022 NovAliX acquires Sanofi site in Strasbourg and creates Guy Ourisson Research Campus Andrew Lloyd Associates
06-Jan-2022 Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis Andrew Lloyd Associates
05-Jan-2022 B-cell lymphoma clinical trials now open on the TrialWire Platform TrialWire
05-Jan-2022 Autism clinical trials now open on the TrialWire Platform TrialWire
05-Jan-2022 Junshi Biosciences and DotBio Announce Collaboration to Develop next-generation antibody therapy with DotBody Module DotBio
04-Jan-2022 Bond Digital Health secures £1 million funding boost Bond Digital Health